The US Meals and Drug Administration has warned wholesalers, retail pharmacies, well being care practitioners, and sufferers about counterfeit variations of Novo Nordisk’s diabetes drug Ozempic. The drug has been tailored into a well-liked weight reduction drug, taking Western nations by storm.
Bloomberg studies the FDA seized hundreds of Ozempic items that had been discovered within the nation’s drug provide chain. It warned wholesalers and docs in opposition to distributing or promoting Ozempic with lot quantity NAR0074 and serial quantity 430834149057 on the packaging.
Danish drugmaker Novo Nordisk and the FDA are testing the counterfeit Ozempic to research its contents.
“FDA and Novo Nordisk (producer of Ozempic) are testing the seized merchandise and don’t but have details about the medicine’ id, high quality, or security,” the FDA warned.
Novo identified that counterfeit Ozempic was present in warehouses outdoors its approved provide chain. Different counterfeit parts had been needles, pen labels, cartons, and affected person data.
“The sterility of the needles can’t be confirmed, which presents an elevated threat of an infection for sufferers who use the counterfeit merchandise,” the FDA acknowledged.
A requirement-driven scarcity of Ozempic and Wegovy is overwhelming Novo’s provide chain for medicine throughout North America and Europe as criminals make the most of the hype cycle with counterfeits.
Loading…